Art'Health: Effects of Artistic and Participative Workshops at the MAMAC of Nice on the Health of Seniors

Centre Hospitalier Universitaire de Nice127 enrolled

Overview

Study with two arms, one of which receives an intervention in the form of participative artistic workshops at the MAMAC and the other was assigned as the control group. Well-being, Quality of life, Health, Apathy and Olfactory identification scales are proposed before the intervention, during the intervention at the end of each month (M1, M2, M3), 6 months after the end of the intervention (M9) and 12 months after the end of the intervention (M15).

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

127

Conditions

Well Aging

Interventions

Artistic activiesOTHER

12 workshops of artictic activities during 12 weeks

Eligibility

Sex: ALLMin age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Be 65 years of age at the time of signing the consent, 2. Having internet access and an electronic tool (smartphone and/or tablet) at home as repeated assessments will be proposed on a dedicated and secure internet platform, 3. To master the French language, 4. To be available during participatory workshop sessions at MAMAC. 5. Be affiliated to Social Security Exclusion Criteria: 1. Do not master the French language, 2. Severe sensory and/or cognitive impairment identified by the IP and their representatives during the inclusion interview, 3. Person under guardianship, curatorship or safeguarding of justice, 4. Person unable to give or sign consent.

Locations (1)

Centre Mémoire de Ressources et de Recherche, CHU de Nice

Nice, France

Outcomes

Primary Outcomes

changes of well being level

well being scale assessment Warwick-Edimbourg Mental Well-Being State (WEMWBS) maximum value : 70 (better outcome) minimum value :14 (worse outcome)

Time frame: before the intervention, during the intervention at the end of each month (Month1, Month 2, Month 3), 6 months after the end of the intervention (Month 9) and 12 months after the end of the intervention (Month 15)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.